Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

lorazepam injection, USP CARPUJECT How Supplied/Storage and Handling (LORAZEPAM (NDC 0409-1985-30))

HOW SUPPLIED

Lorazepam injection, USP is available as:

Unit of SaleConcentration

NDC 0409-1539-31
Carton containing 10
1 mL fill Single-dose cartridge with Luer Lock for the Carpuject™ Syringe System

4 mg/mL

NDC 0409-1985-30
Carton containing 10
1 mL fill Single-dose cartridge with Luer Lock for the Carpuject™ Syringe System

2 mg/mL

Instructions for Use of the Syringe Systems

Instructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.

Directions for Dilution for intravenous use.

1.
Carpuject™: Extrude the entire amount of air in the partially-filled cartridge.
2.
Slowly aspirate the desired volume of diluent. Do not exceed the volume of the drug.
3.
Do not add additional medication to the syringe.
4.
Pull back slightly on the plunger to provide additional mixing space.
5.
Immediately mix contents thoroughly by gently inverting syringe or cartridge repeatedly until a homogenous solution results. Do not shake vigorously, as this will result in air entrapment.

For intramuscular use.

For intravenous route, see directions.

To prevent needle-stick injuries, needles should not be recapped, purposely bent, or broken by hand.

Protect from light. Use carton to protect contents from light.

Keep in a refrigerator 2° to 8°C (36° to 46°F).

Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.